Gut Microbiome Composition Varies in Atherosclerotic Cardiovascular Disease


NEW YORK (GenomeWeb) – The gut microbiomes of people with atherosclerotic cardiovascular disease differ greatly from those of healthy people, according to a new study.

Previous work has suggested that the gut microbiome may influence the development of atherosclerosis. Microbes in the gut metabolize choline, phosphatidylcholine, and L-carnitine to produce trimethylamine (TMA), which is transformed in the liver into trimethylamine-N-oxide (TMAO), a major cause of atherosclerosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
.



Read more

Leave A Comment

Your email address will not be published. Required fields are marked *